Bard Peripheral Vascular

Bard Peripheral Vascular is a medical device business focused on peripheral vascular intervention and vascular access products rather than a drug-development biotech pipeline. Historically it operated as a subsidiary/business unit of C. R. Bard and has been integrated into BD following BD's acquisition of C. R. Bard completed on December 29, 2017. The business is associated with products used in angioplasty, stents, thrombectomy and retrieval, vascular grafting, ports, catheters, PICCs, and related endovascular and access procedures. Its portfolio serves interventional radiology, vascular surgery, oncology access, and hospital-based infusion and access care. The brand/entity remains visible in product labeling, litigation records, and legacy documentation, especially for products developed in Tempe, Arizona.